Management of hypogammaglobulinemia

Indian Pediatrics

Volumn 38, Issue 8, 2001, Pages 864-871

  Lakshman, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; PROTEIN TYROSINE KINASE; TETANUS TOXOID;

ANTIBODY RESPONSE; B LYMPHOCYTE; BRONCHIECTASIS; COMMON VARIABLE IMMUNODEFICIENCY; EARLY DIAGNOSIS; GENETIC COUNSELING; HUMAN; HYPERIMMUNOGLOBULINEMIA; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOTHERAPY; RECURRENT INFECTION; REVIEW; T LYMPHOCYTE; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE;

EID: 0034869446     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. BMJ 1994; 308: 581-585.
2. Skull S, Kemp A. Treatment of hypogammaglobulinemia with intravenous immunoglobulin, 1973-93. Arch Dis Child 1996; 74: 527-530.
3. Cunningham CK, Bonville CA, Ochs HD, Seyama K, John PA, Rotbart H, et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr 1999; 134: 584-588.
4. Smith J, Finn A. Antimicrobial prophylaxis. Arch Dis Child 1999; 80: 388-392.
5. Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000; 20: 94-100.
6. Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998; 79: 48-51.
7. Chapel HM. Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissible agents. Clin Exp Immunol 1999; 118(suppl) 1: 29-34.
8. Stiehm ER, Casillas AM, Finkelstein JZ, Gallagher KT, Groncy PM, Kobayash RH et al. Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: Use of an old method with a new product. J Allergy Clin Immunol 1998; 10: 848-849.
9. Hadzic N, Pagliuca A, Rela M, Portmann B, Jones A, Veys P, et al. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med 2000; 342: 320-324.
10. Kato T, Tsuge I, Inaba J, Kato K, Matsuyama T, Kojima S. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. Bone Marrow Transplant 1999; 23(10): 1081-1083.